American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series: Selected Topics in Malignant Pleural Disease.
Autor: | Chrissian AA; Division of Pulmonary, Critical Care, Hyperbaric, and Sleep Medicine, Loma Linda University Health, Loma Linda, CA., Abbas H; Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD., Chaddha U; Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai Beth Israel Morningside and West Hospitals, New York, NY., Debiane LG; Division of Pulmonary and Critical Care Medicine, Henry Ford Health, Detroit, MI., DeBiasi E; Department of Internal Medicine Section of Pulmonary Critical Care and Sleep Medicine, Yale University, New Haven, CT., Filsoof D; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona College of Medicine, Tucson, AZ., Hashmi MD; Division of Pulmonary and Critical Care Medicine, Henry Ford Health, Detroit, MI., Morton C; Department of Internal Medicine Section of Pulmonary Critical Care and Sleep Medicine, Yale University, New Haven, CT., Naselsky WC; Division of Cardiothoracic Surgery, University of Maryland School of Medicine, Baltimore, MD., Pannu J; Division of Pulmonary, Critical Care and Sleep Medicine Ohio State University Wexner Medical Center, Columbus, OH., Ronaghi R; Division of Pulmonary, Critical Care, Sleep Medicine, Clinical Immunology and Allergy, David Geffen School of Medicine at UCLA, Los Angeles, CA., Salguero BD; Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai Beth Israel Morningside and West Hospitals, New York, NY., Salmon C; Department of Medicine, Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC., Stewart SJ; Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, MD., Channick CL; Division of Pulmonary, Critical Care, Sleep Medicine, Clinical Immunology and Allergy, David Geffen School of Medicine at UCLA, Los Angeles, CA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of bronchology & interventional pulmonology [J Bronchology Interv Pulmonol] 2024 Dec 20; Vol. 32 (1). Date of Electronic Publication: 2024 Dec 20 (Print Publication: 2025). |
DOI: | 10.1097/LBR.0000000000000999 |
Abstrakt: | The goal of the American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series is to provide clinicians with concise, up-to-date reviews of important topics in the field of interventional pulmonology. This 3-year alternating rotation of primary topics will start with a focus on selected topics in malignant pleural disease. In this article, we update the reader on malignant pleural effusion in 3 parts: part 1-diagnosis, focusing on imaging and fluid biomarkers; part 2-management, with review of multimodal approaches, cost considerations, and evolving targeted therapies; and part 3-pleural mesothelioma. These reviews complement the Essential Knowledge in Interventional Pulmonology Lecture Series presented at the 2023 AABIP Annual Conference, available for viewing on the AABIP website (https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series). Competing Interests: Disclosure: A.A.C.: consultant for Intuitive Inc. The remaining authors have no conflict of interest or other disclosures. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |